Prevention of Deep Vein Thrombosis by Panax Notoginseng Saponins Combined with Low-Molecular-Weight Heparin in Surgical Patients

被引：0
作者：
Chun-mei Wang
Xiang-feng Guo
Li-min Liu
Ying Huang
Liang Meng
Li-po Song
Ying-feng Wu
Ya-chan Ning
Kathleen H. Reilly
Hai-bo Wang
机构：
[1] Capital Medical University,Department of Vascular Surgery, Xuanwu Hospital
[2] Children’s Hospital Capital Institute of Pediatrics,Department of Orthopaedics, Xuanwu Hospital
[3] Capital Medical University,Peking University Clinical Research Institute
[4] Centers for Disease Control and Prevention,undefined
[5] Peking University First Hospital,undefined
来源：
Chinese Journal of Integrative Medicine | 2022年 / 28卷
关键词：
panax notoginseng saponins; deep vein thrombosis; low-molecular-weight heparin; thromboelastography; risk factor;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：771 / 778
页数：7
相关论文
共 50 条
  • [31] A comparison of indobufen and low-molecular-weight heparin in the prevention of deep vein thrombosis in patients after total hip arthroplasty: a prospective randomized controlled study
    Huo, Jia
    Li, Mengnan
    Liu, Bo
    Liu, Jia
    Ma, Wenhui
    Wu, Tao
    Li, Huijie
    Han, Yongtai
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2019, 12 (03): : 2720 - 2728
  • [32] Low-molecular-weight heparins in the treatment of deep-vein thrombosis
    Martineau, P
    Tawil, N
    ANNALS OF PHARMACOTHERAPY, 1998, 32 (05) : 588 - +
  • [33] Network pharmacology analysis and clinical verification of Panax notoginseng saponins in deep venous thrombosis prevention
    Yan, Bin
    Ning, Yachan
    Guo, Julong
    Liu, Limin
    Wang, Chunmei
    BIOMEDICAL REPORTS, 2025, 22 (01)
  • [34] A RANDOMIZED CONTROLLED TRIAL OF A LOW-MOLECULAR-WEIGHT HEPARIN (ENOXAPARIN) TO PREVENT DEEP-VEIN THROMBOSIS IN PATIENTS UNDERGOING VASCULAR-SURGERY
    FARKAS, JC
    CHAPUIS, C
    COMBE, S
    SILSIGUEN, M
    MARZELLE, J
    LAURIAN, C
    CORMIER, JM
    EUROPEAN JOURNAL OF VASCULAR SURGERY, 1993, 7 (05): : 554 - 560
  • [35] Foot Pump Versus Low-Molecular-Weight Heparin for Preventing Deep Vein Thrombosis Following Surgery for Hip and Knee Replacement
    Lin, Feng-Fei
    Chen, Bin
    Lin, Chao-Hui
    Zheng, Ke
    INTERNATIONAL SURGERY, 2021, 105 (1-3) : 389 - 396
  • [36] REGRESSION OF DEEP-VEIN THROMBOSIS BY IV-ADMINISTRATION OF A LOW-MOLECULAR-WEIGHT HEPARIN - RESULTS OF A PILOT-STUDY
    KIRCHMAIER, CM
    LINDHOFFLAST, E
    RUBESAM, D
    SCHARRER, I
    VIGH, Z
    MOSCH, G
    WOLF, H
    BREDDIN, HK
    THROMBOSIS RESEARCH, 1994, 73 (05) : 337 - 348
  • [37] Deep vein thrombosis prevention in joint arthroplasties - Continuous enhanced circulation therapy vs low molecular weight heparin
    Gelfer, Y
    Tavor, H
    Oron, A
    Peer, A
    Halperin, N
    Robinson, D
    JOURNAL OF ARTHROPLASTY, 2006, 21 (02) : 206 - 214
  • [38] Treatment of deep venous thrombosis with low-molecular-weight heparin during pregnancy
    Ulander, VM
    Stenqvist, P
    Kaaja, R
    THROMBOSIS RESEARCH, 2002, 106 (01) : 13 - 17
  • [39] Comparison of Fondaparinux and Low-Molecular-Weight Heparin in the Treatment of Portal Vein Thrombosis in Cirrhosis
    Senzolo, Marco
    Piano, Salvatore
    Shalaby, Sarah
    Tonon, Marta
    Tonello, Silvia
    Zanetto, Alberto
    Sacerdoti, David
    Simioni, Paolo
    Bombonato, Giancarlo
    Burra, Patrizia
    Angeli, Paolo
    AMERICAN JOURNAL OF MEDICINE, 2021, 134 (10) : 1278 - +
  • [40] Low-molecular-weight heparin (LMWH) in the treatment of thrombosis
    Holzheimer, RG
    EUROPEAN JOURNAL OF MEDICAL RESEARCH, 2004, 9 (04) : 225 - 239
12345